Maladie de Lyme

Guide d'intervention pour la maladie de Lyme — Édition 2013

Le guide est un outil de référence pour toute intervention de santé publique à la suite de la déclaration d’un cas de maladie de Lyme. Il a été produit à l’intention des professionnels qui interviennent auprès de la personne potentiellement exposée à cette bactérie et des professionnels des directions de santé publique qui soutiennent les intervenants de première ligne du réseau de la santé. 



Staphylococcus aureus résistant à la méthicilline (SARM)

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant StaphylococcusAureus Infections in Adults and Children

Oxford Journals, janvier 2011

[Extrait] Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.


Tuberculose (anglais)

Active Tuberculosis Diagnosis and Management Guideline

Alberta Medical Association, 2007

This guideline focuses on detection of active pulmonary tuberculosis (TB) that poses a public health risk. The rate of TB in Alberta has increased in the past two years and delays in the diagnosis of tuberculosis have resulted in increased morbidity and mortality, increased transmission of infection, greater need for prolonged isolation, and ultimately higher healthcare costs.